fbpx
Disruptor 50 2023
October 2023

Disruptor 50 Summit

What areas and sectors are ripe for disruption? Which technologies and innovations will power the next upheaval in the business world?

The Disruptor 50 is CNBC’s annual list of breakthrough venture-backed startups developing revolutionary new technology into scalable business models to build the next generation of great public companies. Join Disruptor 50 leaders, founders and investors, along with startup founders from around the world as we honor the class of 2023

PAST SPEAKERS

Stéphane Bancel

Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of Moderna’s board of directors since March 2011. Before joining the company, Mr. Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMérieux SA. From July 2000 to March 2006, he served in various roles at Eli Lilly and Company, including as Managing Director, Belgium and as Executive Director, Global Manufacturing Strategy and Supply Chain. Prior to Lilly, Mr. Bancel served as Asia-Pacific Sales and Marketing Director for bioMérieux.

Mr. Bancel currently serves on the board of directors of Indigo. He is currently a Venture Partner at Flagship Pioneering. Mr. Bancel holds a Master of Engineering degree from École Centrale Paris (ECP), a Master of Science in chemical engineering from the University of Minnesota, and an M.B.A. from Harvard Business School.

Jenny Just

Jenny Just co-founded PEAK6 in 1997 with $1.5M in seed capital as a proprietary options trading firm. Since then, she has grown it into a multibillion-dollar financial services and technology giant housing the next generation of products and service brands including PEAK6 Capital Management, PEAK6 Strategic Capital, Apex Fintech Solutions, Apex Crypto, PEAK6 InsurTech, Evil Geniuses, and Zogo. Jenny and her co-founder have created or turned around more than 15 operating companies and made 100s of private investments.

Jenny is passionate about finding opportunities for women to succeed at every table. This passion led her to launch Poker Power in 2020, a woman-led company that teaches poker to all who identify as female and by extension, teaches women strategic thinking, capital allocation, and decision-making skills. Additionally, Jenny has created programs to help women and underrepresented professionals advance their careers including the Women’s Trading Experience, Women’s Technology Experience and Fintech In Action.

Ryan Petersen

Ryan Petersen is the Founder and Co-CEO of Flexport. Prior to starting Flexport to fix the user experience in global trade, Ryan was co-founder and CEO of ImportGenius.com, a data-as-a-service business for global shipping. He holds a degree in economics from the University of California, Berkeley and an MBA from Columbia University.

Anne Wojcicki

Anne co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process. Prior to founding 23andMe, Anne spent a decade on Wall Street investing in healthcare and felt frustrated by a system built around monetizing illness instead of incentivizing prevention. She wanted to flip that model on its head and build a business that helps people prevent illness rather than profit from it. Anne focused on empowering people with direct access to genetic information so that they could use their data to make decisions that could lower their risks for disease. Under her leadership, 23andMe now provides the only personal genetic test with FDA authorization to deliver health information directly to consumers.

A pioneer in the direct-to-consumer DNA testing space, Anne’s vision and persistence have not only allowed 23andMe to provide millions with access to genetic information, but have powered an industry-first crowdsourcing approach to genetic research and drug development – yielding more than 200 scientific publications and two therapeutic programs in phase 1 clinical trials.

Anne graduated from Yale University with a BS in Biology.

LEARN MORE

FOR QUESTIONS ABOUT THE DISRUPTOR 50 LIST OR ANNUAL EVENT, PLEASE REACH OUT TO US AT  Disruptor50@CNBC.com

ALL SESSIONS FROM CNBC D50X 2022 ARE AVAILABLE TO VIEW HERE